Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 3.23B | $ 3.37B | $ 4.07B | $ 4.53B | $ 6.47B |
Total Assets | $ 53.53B | $ 49.77B | $ 51.58B | $ 50.88B | $ 53.51B |
Total Debt | $ 23.88B | $ 21.39B | $ 22.83B | $ 22.84B | $ 25.43B |
Net Debt | $ 20.64B | $ 18.02B | $ 18.76B | $ 18.30B | $ 18.96B |
Total Liabilities | $ 37.69B | $ 34.48B | $ 39.52B | $ 39.20B | $ 41.44B |
Stockholders Equity | $ 15.84B | $ 15.30B | $ 12.06B | $ 11.68B | $ 12.07B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |